What is Sarepta Therapeutics Inc (SRPT)'s P/E Ratio?
The P/E ratio of Sarepta Therapeutics Inc is 8.1651
Who is the CEO of Sarepta Therapeutics Inc?
Mr. Douglas Ingram is the Chief Executive Officer of Sarepta Therapeutics Inc, joining the firm since 2017.
What is the price performance of SRPT stock?
The current price of SRPT is $22.39, it has increased 27.14% in the last trading day.
What are the primary business themes or industries for Sarepta Therapeutics Inc?
Sarepta Therapeutics Inc belongs to Biotechnology industry and the sector is Health Care
What is Sarepta Therapeutics Inc market cap?
Sarepta Therapeutics Inc's current market cap is $2.3B
Is Sarepta Therapeutics Inc a buy, sell, or hold?
According to wall street analysts, 28 analysts have made analyst ratings for Sarepta Therapeutics Inc, including 7 strong buy, 6 buy, 16 hold, 4 sell, and 7 strong sell